GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.25 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 46.97 |
| 52-week low 3 | 28.47 |
| 50-day moving average 3 | 34.93 |
| 200-day moving average 3 | 41.47 |
Share statistics
| Avg vol (3-month) 3 | 6.87M |
| Avg vol (10-day) 3 | 7.93M |
| Shares outstanding 5 | 2.52B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 1.96B |
| % held by insiders 1 | 0.03% |
| % held by institutions 1 | 10.81% |
| Shares short (14 Jul 2022) 4 | 5.57M |
| Short ratio (14 Jul 2022) 4 | 1.28 |
| Short % of float (14 Jul 2022) 4 | N/A |
| Short % of shares outstanding (14 Jul 2022) 4 | 0.27% |
| Shares short (prior month 14 Jun 2022) 4 | 7.11M |
Dividends & splits
| Forward annual dividend rate 4 | 2.48 |
| Forward annual dividend yield 4 | 5.89% |
| Trailing annual dividend rate 3 | 0.80 |
| Trailing annual dividend yield 3 | 2.72% |
| 5-year average dividend yield 4 | 5.25 |
| Payout ratio 4 | 81.99% |
| Dividend date 3 | 05 Oct 2022 |
| Ex-dividend date 4 | 18 May 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 11 Nov 1991 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 12.24% |
| Operating margin (ttm) | 23.48% |
Management effectiveness
| Return on assets (ttm) | 6.58% |
| Return on equity (ttm) | 24.71% |
Income statement
| Revenue (ttm) | 37.24B |
| Revenue per share (ttm) | 18.56 |
| Quarterly revenue growth (yoy) | 18.70% |
| Gross profit (ttm) | 22.66B |
| EBITDA | 11.11B |
| Net income avi to common (ttm) | 4.57B |
| Diluted EPS (ttm) | 2.88 |
| Quarterly earnings growth (yoy) | -39.90% |
Balance sheet
| Total cash (mrq) | 6.53B |
| Total cash per share (mrq) | 3.24 |
| Total debt (mrq) | 22.11B |
| Total debt/equity (mrq) | 97.67 |
| Current ratio (mrq) | 1.43 |
| Book value per share (mrq) | 5.94 |
Cash flow statement
| Operating cash flow (ttm) | 10.51B |
| Levered free cash flow (ttm) | -9.89B |
© 2022 Yahoo. All rights reserved.
